PUR 7776 Single Source with Ocean Alchemists, LLC.pdf

PUR 7776 (01/16) Page 1 of 4 60A-1.045, F.A.C.

DESCRIPTION OF INTENDED

SINGLE SOURCE PURCHASE

(PUR 7776)

AGENCY: Department of Environmental Protection

TITLE: Single Source with Ocean Alchemists, LLC Short description of the commodity or service desired: Manufacture and delivery of Coral Ointment for the treatment of Stony Coral Tissue Loss Disease (SCTLD).

CONTACT

Name: Belinda Croft Address: 3800 Commonwealth Blvd., MS93, Tallahassee, Florida 32399 Telephone: 850.245.2467 Email: Belinda.Croft@FloridaDEP.gov

Internal tracking number, if any: 2022SS012

Date posted: May 9, 2022 Last day for receipt of information: May 31, 2022

This description of commodities or contractual services intended for purchase from a single source is posted in accordance with Sections 120.57(3) and 287.057(3), Florida Statutes, and will remain posted for a period of at least 7 business days.

Commodity or Contractual Service Required (commodity or United National Standard Products and Services Code (UNSPSC), manufacturer, model, and description, as appropriate):

81171500: Marine Biology Services 70161702: Marine Ecosystem Management Services 70161704: Ecosystems Protection Services 70161706: Coastal Ecology and Conservation Service

Quantity or Term (as appropriate):

12 months

Requestor (division, bureau, office, individual, as appropriate):

Office of Resilience and Coastal Protection (ORCP), Coral Protection and Restoration Program

(CPRP)

Performance and/or Design Requirements (e.g. intended use, function or application, compatibility, requirements; reference to policy, rule, statute or other act of the Legislature, etc., as appropriate):

FY22-23 GAA funds in Specific Appropriation 1762A are provided for coral reef restoration and protection efforts.

Task 1 Deliverable-Manufacture/Delivery of Coral Ointment 7/1/2022-12/31/2022 ($18,450.00) Task 1 Deliverable- Manufacture/Delivery of Coral Ointment 1/1/2023-6/30/2023 ($18,450.00) Total: $36,900.00

PUR 7776 (01/16) Page 2 of 4 60A-1.045, F.A.C.

Background:

Florida’s Coral Reef is currently experiencing a multi-year disease-related mortality event, that has resulted in massive die-offs in multiple coral species. Approximately 21 species of coral, including both Endangered Species Act-listed and the primary reef-building species, have displayed tissue loss lesions which often result in whole colony mortality. First observed near Virginia Key in late 2014, the disease has since spread to the northernmost extent of Florida’s Coral Reef, and southwest past the Marquesas in the Lower Florida Keys. The best available information indicates that the disease outbreak is continuing to spread west and throughout the Caribbean.

Ocean Alchemists LLC, is the developer and supplier of the best available product, a coral ointment which is now being utilized by coral disease response teams to treat high priority corals across Florida’s Coral Reef. Previously developed as part of CoreRx Inc. the founders of Ocean Alchemists LLC have been working with various partners involved in the Florida coral disease response effort to support investigations into various research questions and the development of an effective delivery mechanism for topically applying treatments to individual coral colonies.

Preliminary results show that treatment delivered by this coral ointment has a ~75% success rate in stopping individual disease lesions from progressing across a coral colony. As corals without treatments have suffered complete mortality and other treatments have had much lower success rates, this is the best treatment option currently available and is believed to be helping to save hundreds of corals which would have otherwise already perished from disease.

Project Goals and Objectives:

The goal of this project is to continue to manufacture and supply disease response teams in Florida with ‘CoralCure Ointment Base2B’ for the active lesion-level treatment of corals with SCTLD. Base2B has proven to be ~75% effective against the disease in recorded treatments throughout Florida over the last year, depending on the species. Continued supply of ointment will allow for hundreds of corals to continue to receive treatment for SCTLD in 2022 and 2023.

It is requested that reasonable efforts will be made by the research parties involved to provide credit to Ocean Alchemists LLC on any publications or press utilizing the products provided under the Scope of Work. It is also requested that any information provided about the product’s composition (including the distribution of Safety Data Sheets) will be kept as proprietary information.

The outcomes of this project will be incorporated into an on-going coral disease response effort which seeks to improve understanding about the scale and severity of the coral disease outbreak on Florida’s Coral Reef, identify primary and secondary causes, identify management actions to remediate disease impacts, restore affected resources, and ultimately prevent future outbreaks.

As such, collaboration amongst partners is encouraged when appropriate to avoid duplication of efforts and ensure alignment of needs. Coordination with other Principal Investigators is recommended and required, as appropriate.

Methods and Quality Assurance This Scope of Work has been reviewed and approved by the Disease Advisory Committee.

Furthermore, activities detailed herein will be conducted under the advisement of the Disease

PUR 7776 (01/16) Page 3 of 4 60A-1.045, F.A.C.

Advisory Committee and the Steering Committee as needed/appropriate, ensuring that methodologies are not duplicated, best practices are employed, and project results are effectively communicated to all stakeholders. The project objectives and methodology detailed in this Scope of Work are the outcome of the annual Coral Disease Technical Workshop; this project is fulfilling a priority recommendation(s) from the experts convened during that workshop.

All test methods are internally peer reviewed and testing will be conducted against known standards on validated and calibrated instrumentation. This includes pipettes, balances, and UV Spectrometers. Manufacturing processes are captured in standard operating procedures (SOPs).

Task Description and Deliverables:

Task 1: Manufacture and Delivery of Coral Ointment - • Between 98.4–196.8 kgs of coral ointment Base2B will be manufactured and shipped to Florida disease response strike teams on a monthly basis. A spreadsheet of shipment tracking will be provided as a deliverable including the Recipient, Quantity Sent, Date Shipped, and Date Received.

Deliverables:

• Spreadsheet tracker of ointment shipments including recipient, quantity, date shipped, and date received.

All deliverables shall be submitted electronically unless otherwise indicated. All raw data acquired for this project must be submitted to DEP at the end of the project.

All final deliverables and invoice(s) will be submitted to DEP by June 15, 2023 or earlier. DEP may take up to two weeks to review deliverables.

The contractor must notify DEP when data from this project will be published. All deliverables, presentations, and social media posts will acknowledge the financial assistance provided by DEP’s Coral Protection and Restoration Program.

Timeline: July 1, 2022 – June 30, 2023 Task #1- Manufacture/Delivery of Ointment | 49.2 – 98.4 kgs of coral ointment manufactured and shipped to Florida disease response strike teams | 7/1/2022 - 12/31/2022 ($18,450.00) Deliverables Due - Task 1: Manufacture/Delivery of Ointment | Spreadsheet of shipments for 7/1/2022-12/31/2022 including: Recipient, Quantity Sent, Date Shipped, and Date Received | 1/1/2023 | Payment 1: $18,450.00

Manufacture/Delivery of Ointment | 49.2–98.4 kgs of coral ointment manufactured and shipped to Florida disease response strike teams | 1/1/2023 - 6/30/2023 ($18,450.00) Deliverables Due - Task 1: Manufacture/Delivery of Ointment - Spreadsheet of shipments for 1/1/2023-6/30/2023 including: Recipient, Quantity Sent, Date Shipped, and Date Received 6/30/2023 | Payment 2: $18,450.00 Total Project Cost: $36,900.00

Intended Single Source:

Ocean Alchemists, LLC

Estimated Dollar Amount:

$36,900.00

PUR 7776 (01/16) Page 4 of 4 60A-1.045, F.A.C.

Justification for single source acquisition (what is necessary and unique about the product, service or source; steps taken to confirm unavailability of competition, as appropriate):

The coral ointment provided by Ocean Alchemists, LLC is a sole source product. The creation of this product was contracted specifically for the treatment of Stony Coral Tissue Loss Disease (SCTLD) and is currently the only topical coral ointment application that has been created for this use. We are currently working on a new formulation to deliver treatment which will be the only other available coral ointment for the treatment of SCTLD on the market once it is completed.

Ocean Alchemists, LLC maintains all intellectual property rights to their products and these products must be purchased and distributed directly from this company. There are no agents or dealers authorized to represent these products other than Ocean Alchemists, LLC.

Ocean Alchemists, LLC provides quality scientific solutions, supporting drug development and production for the natural world. Ocean Alchemists LLC prides themselves on creating unique solutions for the novel treatment and proliferation of aquatic non-human organisms. Ocean Alchemists LLC is well versed in the creation of traditional pharmaceutical dosage types along with other exotic methods that may be utilized to benefit a variety of environmental causes.

Ocean Alchemists, LLC warrants that no other items or products are available for purchase that would serve the same purpose or function and there is only one price for the above-named product because of exclusive distribution and marketing rights. Katie Curtis, Ocean Alchemists CEO, 813-285-0888, OceanAlchemists@gmail.com

Approved By (names & titles, as appropriate, e.g., requestor, requestor management, information systems, budget, purchasing):

Lisa Yarborough, Program Administrator Belinda Croft, Purchasing Specialist Supervisor

Prospective vendors are requested to provide information regarding their ability to supply the commodities or contractual services described. If it is determined in writing by the agency, after reviewing any information received from prospective vendors, that the commodities or contractual services are available only from a single source, the agency shall: provide notice of its intended decision to enter a single-source purchase contract in the manner specified in Section 120.57(3), F.S.